Growth Metrics

PAVmed (PAVM) Revenue (2021 - 2025)

PAVmed's quarterly Revenue came in at $81000.0 in Q4 2025, up 710.0% year-on-year from $10000.0 in Q4 2024, and up 1520.0% quarter-over-quarter from $5000.0 in Q3 2025.

PAVmed has reported Revenue for 5 years, with the latest figure at $81000.0 in Q4 2025.

  • For the quarter ending Q4 2025, Revenue rose 710.0% year-over-year to $81000.0; the trailing twelve-month figure through Dec 2025 stood at $100000.0 (down 96.72% YoY), and the FY2025 full-year result was $100000.0, down 96.66% from the prior year.
  • Revenue for Q4 2025 stood at $81000.0, up from $5000.0 in the prior quarter.
  • The five-year high for Revenue was $1.0 million in Q4 2023, with the low at $5000.0 in Q3 2025.
  • Average Revenue over 5 years is $339250.0, with a median of $177500.0 recorded in 2022.
  • Year-over-year, Revenue surged 940.79% in 2023 and sank 99.39% in 2025.
  • Tracing PAVM's Revenue over 5 years: stood at $300000.0 in 2021, then slumped by 62.67% to $112000.0 in 2022, then soared by 836.61% to $1.0 million in 2023, then sank by 99.05% to $10000.0 in 2024, then jumped by 710.0% to $81000.0 in 2025.
  • The last three Revenue figures came in at $81000.0 (Q4 2025), $5000.0 (Q3 2025), and $6000.0 (Q2 2025), per Business Quant data.

Peer Comparison

# Company Market Cap Enterprise Value Gross Profit (Qtr) Revenue (Qtr)
1 Abbott Laboratories 152.82 Bn 146.17 Bn 6.27 Bn 11.16 Bn
2 Stryker 115.07 Bn 112.19 Bn 3.81 Bn 6.02 Bn
3 Medtronic 95.25 Bn 87.08 Bn 5.76 Bn 9.02 Bn
4 Boston Scientific 71.38 Bn 70.17 Bn 3.61 Bn 5.20 Bn
5 Edwards Lifesciences 51.08 Bn 47.41 Bn 1.29 Bn 1.65 Bn
6 Koninklijke Philips 29.38 Bn 26.07 Bn 2.07 Bn 4.57 Bn
7 Dexcom 28.84 Bn 27.72 Bn 750.30 Mn 1.19 Bn
8 GE HealthCare Technologies 28.56 Bn 26.49 Bn 1.98 Bn 5.13 Bn
9 Steris 20.71 Bn 20.30 Bn 697.10 Mn 1.59 Bn
10 PAVmed 4.15 Mn -9.02 Mn -703,000.00 81,000.00

Historic Data

Download Data 🔒
DateValue
Dec 31, 2025 81,000.00
Sep 30, 2025 5,000.00
Jun 30, 2025 6,000.00
Mar 31, 2025 8,000.00
Dec 31, 2024 10,000.00
Jun 30, 2024 979,000.00
Mar 31, 2024 1.01 Mn
Dec 31, 2023 1.05 Mn
Sep 30, 2023 791,000.00
Jun 30, 2023 166,000.00
Mar 31, 2023 446,000.00
Dec 31, 2022 112,000.00
Sep 30, 2022 76,000.00
Mar 31, 2022 189,000.00
Dec 31, 2021 300,000.00
Sep 30, 2021 200,000.00